CUMULOCITY
20.4.2016 18:25:05 CEST | Business Wire | Press release
Cumulocity, the global leading provider of ‘Internet-of-Things’ (IoT) software and solutions, and Astea International Inc., the leader in service management and mobile workforce solutions , have teamed up to offer the most advanced and comprehensive end-to-end service management solution available today.
As service delivery grows more complex and competitive, companies committed to achieving service excellence are looking to take advantage of IoT technologies to collect, analyze and act on real-time information from smart assets in the field. This will move the traditional service delivery model beyond the simple alert-dispatch-repair applications to a more proactive, predictive outcomes-based service model.
Cumulocity’s award winning IoT Platform enables companies to collect and analyze information in real-time from connected, smart assets and equipment. It also provides full remote control and management capability enabling for example remote configuration, software update or restart of any equipment. The integration between Cumulocity and Astea seamlessly links the assets in the field to the resources in the service organization so that they can more accurately predict equipment failures, create usage-based maintenance schedules, reduce the number of truck rolls, improve inventory utilization, and meet greater service level agreement (SLA) commitments with fewer resources.
Rapid Results
Specific benefits for customers include:
- Significantly lower service costs . Field and call center technicians are armed with the information they need to rapidly identify and resolve problems on the first contact.
- Greater customer satisfaction & retention. Proactive problem detection often resolves issues before they affect the customer, dramatically increasing product uptime.
- Increased service revenue. Rapid resolution and superior on-demand customer service drive opportunities for increased revenue through new service offerings and business models.
“Cumulocity provides a complete solution for connecting smart assets and analyzing the information in real-time to turn it into intelligent actions. This ability to turn data into action is what creates real business value and we are excited to be working with Astea as their strategic partner for IoT. With this integration, enterprise service organizations will be able to take advantage of real-time information provided by their assets in the field in ways that will improve service, reduce costs, and create new service revenue opportunities and differentiated offerings,” says Jari Salminen, Managing Director at Cumulocity.
“Our customers are demanding greater responsiveness, improved first-time fix rates, and guaranteed equipment uptime. The next generation of service delivery will be more proactive/predictive instead of primarily reactive,” said Deb Geiger, VP Global Marketing, Astea International. “To fulfil this vision, we have selected Cumulocity as our strategic IoT platform and are excited about the opportunities this collaboration brings to our customers,” she continues.
Cumulocity and Astea will be holding a free webinar demonstrating the powerful benefits that this joint solution can offer for service organizations interested in unlocking the potential of IoT. Be among the first to get an exclusive demonstration on Wednesday, May 4, 2016, at 10:30am ET/4:30pm CEST to reserve your spot please visit: Simplifying The Internet of Things for Field Service .
About Cumulocity
Cumulocity is the leading independent Application Enablement and Device Management platform for the Internet-of-Things (IoT) – since 2010. Cumulocity is an open platform that provides a complete feature set for rapidly developing and deploying IoT solutions. The key features include Data collection and Storage, Real-Time Analytics, Real-Time Visualization and Device Management. Our open and publicly documented APIs and the open UI framework, enable our partners and customers to configure and extend the platform to their unique needs.
Scalability, security and reliability are critical in IoT solutions - and our origins as part of Nokia Siemens Networks, the world's mobile broadband specialist, gives us the experience of securely managing millions of devices without service interruptions. And being available both as Cloud and On-Premise deployments, Cumulocity enables enterprises to start small and scale out to millions of devices with the deployment model fit for their business.
For more information and to start your free trial visit www.cumulocity.com .
About Astea International
Astea International is a global provider of software solutions that offer all the cornerstones of service lifecycle management, including customer management, service management, asset management, forward and reverse logistics management and mobile workforce management and optimization. Astea’s solutions link processes, people, parts, and data to empower companies and provide the agility they need to achieve sustainable value in less time, and successfully compete in a global economy. Since 1979, Astea has been helping more than 600 companies drive even higher levels of customer satisfaction with faster response times and proactive communication, creating a seamless, consistent and highly personalized experience at every customer relationship touch point.
www.astea.com. Service Smart. Enterprise Proven.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160420006186/en/
Contact:
Cumulocity
Contact: Philip Hooker
E-mail: mediarelations@cumulocity.com
http://www.cumulocity.com
Phone:
+49 (211) 74951433
or
Astea International
Debbie Geiger
Vice
President, Marketing
215-682-2500
dgeiger@astea.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
